AIV-001

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameAIV-001
Drug Alias NameAIV-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsCicatrixRosaceaKeloid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAiviva Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAiviva Biopharma Inc
Inactive CompaniesN/A
Active IndicationsKeloidSkin NeoplasmsCarcinoma, Basal Cell
Inactive IndicationsCicatrixRosacea

Other Information

ATC CodeN/A
Related LinksN/A